Research at Berlin-Buch

The Berlin-Buch Campus is a unique site for medical research and development in Germany. The Max Delbrück Center for Molecular Medicine (MDC), founded in 1992 as a model for clinical research from three institutes of the GDR Academy of Sciences, was the initial driving force for the development of the campus into a research and biotechnology site of supraregional significance. Since 2000, the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) has played a major role in this development.

Today, on the 32-hectare site which can look back on a long scientific tradition, institutes for basic medical research, research clinics and biotechnology companies are located in close proximity to each other. Buch's researchers, doctors and entrepreneurs are collaborating in the development of new treatments and diagnostic procedures for cancer, cardiovascular and nervous system diseases.

A modern Congress Center with integrated laboratories on the campus offers multiple opportunities for scientific interaction.